A-Alpha Bio Secures $20M Series A Financing!

This morning we announced that we have closed a $20M Series A Financing Round to dramatically expand our capabilities and throughput! The round was led by Madrona Venture Group, our partner since the seed round, accompanied by new investors Xontogeny and Lux Capital. We are also thrilled to welcome Matt McIlwain and Ben Askew to our Board of Directors!

Reaching this milestone less than two years after our seed financing is a strong testament to the dedication of our team and the conviction of our partners and investors. The new capital will allow us to vigorously build upon this momentum ​​– expanding our team, partnering capacity, and computational capabilities.

We are incredibly excited to accelerate our work toward improving human health with synthetic biology & machine learning! Thanks to all who have supported us along the way!

Check out the press release here

Coverage in MedCity News here

Coverage in Geekwire here